President of French Refractive Surgery Society (SAFIR) Purchased LipiFlow® to Improve Care for Evaporative Dry Eye Patients
Catherine Albou-Ganem, MD Embraces LipiFlow®as a Safe and Effective Method for Managing Evaporative Dry Eye
MORRISVILLE, N.C. AND PARIS, FRANCE─ February 13, 2013─TearScience®, a privately held medical device company, today announced that the president of the French Society of Refractive Surgery, Catherine Albou-Ganem, MD, has purchased the TearScience® system for evaluating and treating evaporative dry eye. Dr Albou-Ganem is the first to implement the TearScience® system in France.
Dry eye disease is a common complaint among patients visiting eye care physicians. ...Read More →
TearScience® Reports Significant Market Penetration in Third Quarter
Morrisville, N.C.,—November 1, 2012—TearScience®, Inc., a privately-held medical device company, today reported record bookings with innovative eye care practices during the third quarter for its system for evaluating and treating evaporative dry eye.
“We are very pleased with the rate at which LipiFlow® and LipiView® are being adopted by eye care practices,” said Jeff O’Hara, TearScience’s vice president of sales for North America. “TearScience’s market penetration expanded even though medical device sales typically slow in the third quarter. Record bookings demonstrate our continued progress to becoming the ...Read More →
TearScience® Appoints Wade Hampton as Senior Vice President and Chief Commercial Officer
MORRISVILLE, N.C.─October 19, 2012─TearScience®, a privately held medical device company, today announced the appointment of Wade Hampton as senior vice president and chief commercial officer. Hampton will direct the commercialization of TearScience’s disruptive technology with initial focus on North America, which many eye care physicians are calling the new standard of care for dry eye. Hampton will report directly to TearScience’s chief executive officer, Tim Willis.
TearScience tapped Hampton for his expertise at successfully growing sales and market share for ...Read More →
TearScience®’s LipiFlow® Treatment for Evaporative Dry Eye Debuts in Japanese Market at Minamiaoyama Eye Clinic
MORRISVILLE, N.C.—August 8, 2012—TearScience®, a privately held medical device company, today announced that Dr. Kazuo Tsubota, M.D., PhD. of Japan’s world-renowned Minamiaoyama Eye Clinic in central Tokyo has acquired TearScience’s system for assessing and treating evaporative dry eye disease. It is estimated that more than 8 million people in Japan suffer from dry eye. Japan’s dry eye market is estimated at greater than $800 million annually and growing due to the country’s rapidly aging population and increased reliance on ...Read More →
TearScience® Signs Exclusive Distributor Agreement With Italy’s Ophthalmology Leader NewTech SpA
MORRISVILLE, N.C. and MILAN, ITALY—June 20, 2012—TearScience®, a privately held medical device company, today announced it has signed an exclusive distributor agreement with NewTech SpA, Italy’s premier distributor of ophthalmic medical devices. NewTech will distribute TearScience’s system for assessing and treating evaporative dry eye disease to eye care practices throughout Italy.
Some 100 million people worldwide suffer from dry eye. Italy, with its large elderly population, has a high prevalence of dry eye. Approximately 50 percent of the Italian population ...Read More →
TearScience® Signs Exclusive Korean Distributor Agreement With Industry Leader HumanPlus Tech
MORRISVILLE, N.C.,— June 5, 2012—TearScience®, a privately held medical device company, today announced it has signed an exclusive distributor agreement for the Korean market with HumanPlus Tech, Korea’s leading distributor for ophthalmic medical devices and products. HumanPlus Tech will distribute TearScience’s system for assessing and treating evaporative dry eye disease to eye care practices nationwide.
Some 100 million people worldwide suffer from dry eye. Studies published in May, 2011 in the Archives of Ophthalmology show that one ...Read More →
TearScience Granted Patents on LipiView® Medical Device
Patented LipiView® Ocular Surface Interferometer Helps Physicians Assess Dry Eye Patients
MORRISVILLE, N.C.,— January 3, 2012—TearScience, Inc., a venture funded medical device company, today announced it has been granted several patents on its LipiView® Ocular Surface Interferometer medical device. The LipiView® allows eye care physicians to assess the tear film of dry eye patients.
The LipiView® uses interferometric imaging to capture, manipulate, analyze, and store digital images of the tear film. TearScience’s patents (7,758,190; 7,988,294; and D614,774) cover ...Read More →